Search Resources (English): Drug controls, Women and Health Protection (WHP)

6 results


International harmonisation of new drugs regulation: not in women's best interest

Examines the question of harmonisation of pharmaceutical regulation and its implications for women and public health. Urges that safety standards be paramount and the particular needs of women and other groups are not lost.

 (See Details)
Published: 2003
Women and adverse drug reactions: reporting in the Canadian context

Examines the Canadian system of adverse drug reactions reporting and that women’s particular susceptibilities to drug-related health risks must be taken into consideration.

 (See Details)
Published: 2003
Direct-to-consumer advertising of prescription drugs

Outlines concerns about direct-to-consumer advertising, including lack of public regulation and targeting of already healthy populations.

 (See Details)
Published: 1999
Reporting harm caused by medicines
Discusses why women should report all cases of known or suspected harm from prescription drugs and medicines. Provides contact information for consumers who wish to file a report. (See Details)
Published: 2005
Post-market surveillance of therapeutic drugs in Canada
Discusses the importance of an effective post-market surveillance system of therapeutic drugs. Lists problems with the current system, and argues that improvements will only occur when there is greater consumer involvement. (See Details)
Published: 2005
Who benefits: international harmonisation of the regulation of new pharmaceutical drugs
Explains how the push to streamline the drug approval process in the world's three largest pharmaceutical markets is neglecting the special needs of women. (See Details)
Published: 2002